ArticleArchives of virology2026
Identification of efficient geminivirus-derived LIR-elements for exogenous protein expression.
Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Viral vectors have emerged as powerful platforms for producing medical and metabolite products. To explore how diverse regulatory components can enhance gene expression, and leveraging the abundant diversity of long intergenic regions (LIRs) in geminiviruses, we systematically screened the bidirectional promoter activities of 209 LIR fragments from 8 genera within the Geminiviridae family. This screening was performed using a dual-reporter vector (GFP/Firefly luciferase) via transient expression in Nicotiana benthamiana, leading to the identification of four highly active LIR elements (LIR-2, 37, 51, and 62) derived from three distinct genera. Corresponding geminivirus expression vectors were then constructed based on these LIRs. Among them, the GM2, GM37, and GM62 vectors significantly enhanced GFP/GUS expression levels, showing 1.27 ± 0.20- to 1.82 ± 0.17-fold and 1.16 ± 0.10- to 1.64 ± 0.33-fold increases at 3 dpi, respectively, compared to the cauliflower mosaic virus 35S promoter in the pCAMBIA1300 plant vector. Furthermore, these vectors successfully expressed the medically relevant protein human papillomavirus 16 L1 (HPV16 L1), which is typically difficult to express using the pCAMBIA1300 vector. The GM2 vector exhibited the highest expression level, reaching 1.70 ± 0.38 times that of GM37, underscoring its potential as a superior expression platform. Collectively, the LIR elements identified in this study enrich the toolbox for developing virus-based expression vectors in plants, and are particularly suitable for applications in plant bioreactors requiring simultaneous expression of multiple target molecules.
Indexed as
Identifiers
42096057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.